Yüklüyor......
Development and Validation of an HPLC–MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues †
Pioglitazone (PGZ) is an oral anti-hyperglycemic agent, belongs to the class of thiazolidinediones, and is used for the treatment of diabetes mellitus type 2. In recent years, its anti-inflammatory activity has also been demonstrated in the literature for different diseases, including ocular inflamm...
Kaydedildi:
| Yayımlandı: | Pharmaceutics |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147631/ https://ncbi.nlm.nih.gov/pubmed/34063615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13050650 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|